Cited by 243Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on BehaviorOpioid Use Disorder Treatment

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Pharmacological approaches to methamphetamine dependence: a focused review

Open access

Karila, Laurent, Weinstein, Aviv, Aubin, Henri‐Jean, Benyamina, Amine, Reynaud, Michel, Batki, Steven L.·2010·British Journal of Clinical Pharmacology

DOI 10.1111/j.1365-2125.2010.03639.xPMC PMC2883750

Open this paper in CoChat — free account Open PDF

Abstract

Methamphetamine dependence is a serious worldwide public health problem with major medical, psychiatric, socioeconomic and legal consequences. Various neuronal mechanisms implicated in methamphetamine dependence have suggested several pharmacological approaches. A literature search from a range of electronic databases (PubMed, EMBASE, PsycInfo, the NIDA research monograph index and the reference list of clinicaltrials.gov) was conducted for the period from January 1985 to October 2009. There were no restrictions on the identification or inclusion of studies in terms of publication status, language and design type. A variety of medications have failed to show efficacy in clinical trials, including a dopamine partial agonist (aripiprazole), GABAergic agents (gabapentin) and serotonergic agents (SSRI, ondansetron, mirtazapine). Three double‐blind placebo‐controlled trials using modafinil, bupropion and naltrexone have shown positive results in reducing amphetamine or methamphetamine use. Two studies employing agonist replacement medications, one with d‐amphetamine and the other with methylphenidate, have also shown promise. Despite the lack of success in most studies to date, increasing efforts are being made to develop medications for the treatment of methamphetamine dependence and several promising agents are targets of further research.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2010.03639.x

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W. W., & London, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 770
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669
Drug addiction: the neurobiology of behaviour gone awry
Volkow, N. D., & Li, T. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1539 · Cited by 638
Involvement of the endocannabinoid system in drug addiction
Maldonado, R. J., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 601
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G., Jayne, M. C., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 535
Cognitive enhancing effects of modafinil in healthy volunteers
Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J. H., & Sahakian, B. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1250-8 · Cited by 518
The need for speed: an update on methamphetamine addiction
Barr, A. M., Panenka, W. J., MacEwan, G. W., Thornton, A. E., Lang, D. J., Honer, W. G., & Lecomte, T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0635 · Cited by 441
The prevalence of psychotic symptoms among methamphetamine users
McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391
Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers
London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J. E., Shinn, A. K., Miotto, K. A., Learn, J. E., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 390
A multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence
Rawson, R. A., Marinelli‐Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., et al. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00707.x · Cited by 387
A Systematic Review of Modafinil
Ballon, J. S., & Feifel, D. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0406 · Cited by 351
Stimulant Medication Use, Misuse, and Abuse in an Undergraduate and Graduate Student Sample
White, B. P., Becker‐Blease, K. A., & Grace-Bishop, K. (2006) · Journal of American College Health · doi:10.3200/jach.54.5.261-268 · Cited by 333
Untitled work
(1996) · PubMed · Cited by 328
Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder
Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.008 · Cited by 301
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: Replication study
Volkow, N. D., Wang, G., Fowler, J. S., Thanos, P., Logan, J., Gatley, S. J., Gifford, A. J., Ding, Y., Wong, C., & Pappas, N. R. (2002) · Synapse · doi:10.1002/syn.10137 · Cited by 278
Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil
Bastoji, H., & Jouvet, M. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90014-0 · Cited by 270
Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia
Turner, D. C., Clark, L., Pomarol‐Clotet, E., McKenna, P. J., Robbins, T. W., & Sahakian, B. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300457 · Cited by 260
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & de Wit, H. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240
Modafinil for the treatment of cocaine dependence
Anderson, A. L., Reid, M. S., Li, S.-H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., et al. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.04.015 · Cited by 235
Bupropion for the treatment of methamphetamine dependence
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234
A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
Dwoskin, L. P., & Crooks, P. A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00899-1 · Cited by 220
Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo
Levin, F. R., Evans, S. M., Brooks, D. J., & Garawi, F. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.004 · Cited by 220
Executive control deficits in substance-dependent individuals: A comparison of alcohol, cocaine, and methamphetamine and of men and women
van der Plas, E. A. A., Crone, E. A., van den Wildenberg, W. P. M., Tranel, D., & Bechara, A. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802484797 · Cited by 209
Vaccine Pharmacotherapy for the Treatment of Cocaine Dependence
Martell, B. A., Mitchell, E. S., Poling, J. C., Gonsai, K., & Kosten, T. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.032 · Cited by 208
Enlarged striatum in abstinent methamphetamine abusers: A possible compensatory response
Chang, L., Cloak, C. C., Patterson, K., Grob, C. S., Miller, E. N., & Ernst, T. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 206
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users
McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brašić, J. R., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F., et al. (2007) · Synapse · doi:10.1002/syn.20471 · Cited by 205
A novel strategy for the treatment of cocaine addiction
Dewey, S. L., Morgan, A. E., Ashby, C. R., Horan, B., Kushner, S. A., Logan, J., Volkow, N. D., Fowler, J. S., Gardner, E. L., & Brodie, J. D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 194
A double-blind, placebo-controlled trial of modafinil for cocaine dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.12.014 · Cited by 187
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study
Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J., Rowan, A. B., Poole, S. A., White, L., & O’Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00335-6 · Cited by 186
Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial
Jayaram-Lindström, N., Hammarberg, A., Beck, O., & Franck, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020304 · Cited by 185
A Comparison of Aripiprazole, Methylphenidate, and Placebo for Amphetamine Dependence
Tiihonen, J., Kuoppasalmi, K. I., Föhr, J., Tuomola, P., Kuikanmäki, O., Vorma, H., Sokero, P., Haukka, J. K., & Meririnne, E. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.160 · Cited by 178
Effects of modafinil on working memory processes in humans
M�ller, U., Steffenhagen, N., Regenthal, R., & Bublak, P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1926-3 · Cited by 172
Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving
Newton, T. F., Roache, J. D., Garza, R. D. L., FONG, T. W., Wallace, C. L., Li, S.-H., Elkashef, A. M., Chiang, N., & Kahn, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300979 · Cited by 163
Modafinil: A Double-Blind Multicentric Study
Billiard, M. M., Besset, A., Montplaisir, J. Y., Laffont, F., Goldenberg, F., Weill, J. S., & Lubin, S. (1994) · SLEEP · doi:10.1093/sleep/17.suppl_8.s107 · Cited by 161
Mechanisms of modafinil: A review of current research
Gerrard, P., & Malcolm, R. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a911 · Cited by 160
A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159
Stimulant Psychosis: Symptom Profile and Acute Clinical Course
Harris, D. S., & Batki, S. L. (2000) · American Journal on Addictions · doi:10.1080/10550490050172209 · Cited by 153
Self-citation
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
SHOPTAW, S. J., Heinzerling, K. G., Rotheram-Fuller, E. J., Steward, T., Wang, J., Swanson, A., Garza, R. D. L., Newton, T., & Ling, W. W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.010 · Cited by 150
Psychiatric and Substance Dependence Comorbidities, Sexually Transmitted Diseases, and Risk Behaviors Among Methamphetamine-Dependent Gay and Bisexual Men Seeking Outpatient Drug Abuse Treatment
SHOPTAW, S. J., Peck, J. A., Reback, C. J., & Rotheram-Fuller, E. J. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400511 · Cited by 147
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence
SHOPTAW, S. J., Huber, A., Peck, J. A., Yang, X., Liu, J., Dang, J., Roll, J. M., Shapiro, B., Rotheram-Fuller, E. J., & Ling, W. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.005 · Cited by 146
Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues
Myrick, H., Malcolm, R. J., Taylor, B. R., & LaRowe, S. D. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490453743 · Cited by 137
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function
Fleckenstein, A. E., Haughey, H. M., Metzger, R. R., Kokoshka, J. M., Riddle, E. L., Hanson, J. E., Gibb, J. W., & Hanson, G. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00588-9 · Cited by 136
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence
Johnson, B. A., Ait‐Daoud, N., Elkashef, A. M., Smith, E. V., Kahn, R., Vocci, F., Li, S.-H., Bloch, D. A., & the Methamphetamine Study Group (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007778 · Cited by 131
Aripiprazole for schizophrenia
El-Sayeh, H., Morganti, C., & Adams, C. E. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.189.2.102 · Cited by 129
High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug development
Rothman, R. B. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90466-5 · Cited by 126
Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade
Anggadiredja, K., Nakamichi, M., Hiranita, T., Tanaka, H., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300454 · Cited by 125
A review of rivastigmine: A reversible cholinesterase inhibitor
Williams, B. R., Nazarians, A., & Gill, M. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80160-1 · Cited by 122
Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence
Longo, M., Wickes, W., Smout, M., Harrison, S., Cahill, S., & White, J. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02717.x · Cited by 122
Safety and efficacy of ?-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction
Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121
Prospective memory impairment in former users of methamphetamine
Rendell, P. G., Mazur, M., & Henry, J. D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1408-0 · Cited by 120
Pharmacotherapy of Methamphetamine Addiction: An Update
Elkashef, A. M., Vocci, F. J., Hanson, G. R., White, J. M., WICKES, W. A., & Tiihonen, J. (2008) · Substance Abuse · doi:10.1080/08897070802218554 · Cited by 119
Emerging research on methamphetamine
Maxwell, J. C. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165592.52811.84 · Cited by 116
Approaches to the development of medications for the treatment of methamphetamine dependence
Vocci, F. J., & Appel, N. M. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01772.x · Cited by 114
Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence
Jayaram‐Lindström, N., Konstenius, M., Eksborg, S., Beck, O., Hammarberg, A., & Franck, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301572 · Cited by 107
Corticolimbic dysregulation and chronic methamphetamine abuse
Baicy, K., & London, E. D. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01777.x · Cited by 105
Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine
Frey, K. A., Kilbourn, M. R., & Robinson, T. E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01152-7 · Cited by 104
Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence
Heinzerling, K. G., SHOPTAW, S. J., Peck, J. A., Yang, X., Liu, J., Roll, J. M., & Ling, W. W. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.019 · Cited by 102
Does Modafinil Enhance Cognitive Performance in Young Volunteers Who Are Not Sleep-Deprived?
Randall, D. C., Viswanath, A., Bharania, P., Elsabagh, S., Hartley, D. E., Shneerson, J. M., & File, S. E. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155816.21467.25 · Cited by 97
Methylphenidate and cocaine: the same effects on gene regulation?
YANO, M., & STEINER, H. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.004 · Cited by 94
Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use
Aron, J. L., & Paulus, M. P. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01778.x · Cited by 94
Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels
Vergo, S. B., Johansen, J. L., Leist, M., & Lotharius, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.028 · Cited by 93
Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence
Shearer, J., WODAK, A. D., Mattick, R. P., van Beek, I., Lewis, J. E., Hall, W., & Dolan, K. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96912898.x · Cited by 93
Clinically Significant Drug Interactions with Cholinesterase Inhibitors
Bentu??-Ferrer, D., Tribut, O., Polard, É., & Allain, H. (2003) · CNS Drugs · doi:10.2165/00023210-200317130-00002 · Cited by 92
Suppression of methamphetamine-seeking behavior by nicotinic agonists
Hiranita, T., Nawata, Y., Sakimura, K., Anggadiredja, K., & Yamamoto, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600347103 · Cited by 91
Effects of Naltrexone on the Subjective Response to Amphetamine in Healthy Volunteers
Jayaram‐Lindström, N., Wennberg, P., Hurd, Y. L., & Franck, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144893.29987.e5 · Cited by 88
Electrocardiographic abnormalities in methamphetamine abusers
Haning, W., & Goebert, D. A. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01776.x · Cited by 86
Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users
Lapworth, K., Dawe, S., Davis, P. J., Kavanagh, D. J., Young, R. M., & Saunders, J. B. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.11.014 · Cited by 86
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
McGregor, C., Srisurapanont, M., Mitchell, A., Wickes, W., & White, J. M. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.003 · Cited by 82
Aripiprazole Attenuates the Discriminative-Stimulus and Subject-Rated Effects of D-Amphetamine in Humans
Lile, J., Stoops, W. W., Vansickel, A., Glaser, P., Hays, L., & Rush, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300803 · Cited by 81
The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine‐induced dopaminergic deficits
Volz, T. J., Hanson, G. R., & Fleckenstein, A. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04419.x · Cited by 76
Nonmedical Use of Prescription Stimulants Among Students
Arria, A. M., & Wish, E. D. (2006) · Pediatric Annals · doi:10.3928/0090-4481-20060801-09 · Cited by 76
Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.
Castells, X., Casas, M., Vidal, X., Bosch, R., Roncero, C., Ramos-Quiroga, J., & Capellà, D. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01943.x · Cited by 75
A placebo‐controlled trial of mirtazapine for the management of methamphetamine withdrawal
CRUICKSHANK, C. C., MONTEBELLO, M. E., DYER, K. R., QUIGLEY, A., BLASZCZYK, J., TOMKINS, S., & SHAND, D. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801935672 · Cited by 74
Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats
Byrnes-Blake, K. A., Laurenzana, E. M., Carroll, F. I., Abraham, P., Gentry, W. B., Landes, R. D., & Owens, S. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01313-x · Cited by 73
Modulation of Dopamine Transmission by 5HT2C and 5HT3 Receptors: A Role in the Antidepressant Response
Dremencov, E., Weizman, Y., Kinor, N., Gispan-Herman, I., & Yadid, G. (2006) · Current Drug Targets · doi:10.2174/138945006775515491 · Cited by 73
Lobeline Analogs with Enhanced Affinity and Selectivity for Plasmalemma and Vesicular Monoamine Transporters
Miller, D. K., Crooks, P. A., Zheng, G., Grinevich, V. P., Norrholm, S. D., & Dwoskin, L. P. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068098 · Cited by 73
Bupropion increases striatal vesicular monoamine transport
Rau, K. S., Birdsall, E., Hanson, J. E., Johnson‐Davis, K. L., Carroll, F. I., Wilkins, D. G., Gibb, J. W., Hanson, G. R., & Fleckenstein, A. E. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.05.004 · Cited by 72
Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats
Munzar, P., Baumann, M. H., Shoaib, M. C., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050836 · Cited by 71
Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat
McMillan, D. E., Hardwick, W. C., Li, M., Gunnell, M. G., Carroll, F. I., Abraham, P., & Owens, S. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061762 · Cited by 71
Vaccination against nicotine: an emerging therapy for tobacco dependence
Maurer, P., & Bachmann, M. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1775 · Cited by 70
Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats
Byrnes-Blake, K. A., Carroll, F. I., Abraham, P., & Owens, S. M. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00019-9 · Cited by 69
Lobelane decreases methamphetamine self-administration in rats
Neugebauer‎, N. M., Harrod, S. B., Stairs, D. J., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.003 · Cited by 67
Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward
Anggadiredja, K., Sakimura, K., Hiranita, T., & Yamamoto, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.051 · Cited by 65
Methamphetamine dependence and human immunodeficiency virus risk behavior
Rawson, R. A., Gonzales, R. E., Antonini, V. P., Ang, A., Marinelli‐Casey, P., & Brummer, J. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.11.003 · Cited by 64
Safety of intravenous methamphetamine administration during treatment with bupropion
Newton, T. F., Roache, J. D., Garza, R. D. L., Fong, T., Wallace, C. L., Li, S.-H., Elkashef, A. M., Chiang, N., & Kahn, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0102-8 · Cited by 63
Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers
Newton, T. F., Reid, M. S., Garza, R. D. L., Mahoney, J. J., Abad, A., Condos, R., Palamar, J. J., Halkitis, P. N., Mojisak, J., Anderson, A., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009097 · Cited by 61
Provigil (Modafinil) Plus Cognitive Behavioral Therapy for Methamphetamine Use in HIV+ Gay Men: A Pilot Study
McElhiney, M. C., Rabkin, J. G., Rabkin, R., & Nunes, E. V. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802342907 · Cited by 61
Management of methamphetamine abuse and dependence
Ling, W., Rawson, R., & Shoptaw, S. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0035-x · Cited by 60
Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone
Chiu, C., Ma, T., & Ho, I. K. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.05.028 · Cited by 60
Methamphetamine Dependence: A Closer Look at Treatment Response and Clinical Characteristics Associated with Route of Administration in Outpatient Treatment
Rawson, R. A., Gonzales, R. E., Marinelli‐Casey, P., & Ang, A. (2007) · American Journal on Addictions · doi:10.1080/10550490701389864 · Cited by 58
The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers
Garza, R. D. L., Mahoney, J. J., Culbertson, C., SHOPTAW, S. J., & Newton, T. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.010 · Cited by 58
A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine
Stoops, W. W., Lile, J. A., Glaser, P. E. A., & Rush, C. R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.02.004 · Cited by 57
MEMORY IMPAIRMENT IN METHAMPHETAMINE DEPENDENT PATIENTS
MOON, M., Soo, K., Park, J.-W., & Kim, D. (2007) · International Journal of Neuroscience · doi:10.1080/00207450500535503 · Cited by 57
Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats
Gentry, W. B., Laurenzana, E. M., Williams, D. K., West, J. R., Berg, R. J., Terlea, T., & Owens, S. M. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.008 · Cited by 54
Development of active and passive human vaccines to treat methamphetamine addiction
Gentry, W. B., Rüedi‐Bettschen, D., & Owens, S. M. (2009) · Human Vaccines · doi:10.4161/hv.5.4.7456 · Cited by 52
Effects of acute topiramate dosing on methamphetamine-induced subjective mood
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006401 · Cited by 52
Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats
Byrnes-Blake, K. A., Laurenzana, E. M., Landes, R. D., Gentry, W. B., & Owens, S. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.016 · Cited by 49
Drug-Induced Psychosis Associated with Crystalline Methamphetamine
Dore, G., & Sweeting, M. (2006) · Australasian Psychiatry · doi:10.1080/j.1440-1665.2006.02252.x · Cited by 47
Short-term Treatment of Cocaine and/or Methamphetamine Abuse With Vigabatrin
Fechtner, R. D. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.9.1257 · Cited by 46
Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy)
Nakagawa, T., & Kaneko, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070141 · Cited by 43
Development of Immunopharmacotherapy Against Drugs of Abuse
Meijler, M. M., Matsushita, M., Wirsching, P., & Janda, K. D. (2004) · Current Drug Discovery Technologies · doi:10.2174/1570163043484851 · Cited by 41
Alcohol & Drug Abuse: Long-Acting Stimulants for the Treatment of Attention-Deficit Disorder in Cocaine-Dependent Adults
Castañeda, R., Levy, R., Hardy, M., & Trujillo, M. (2000) · Psychiatric Services · doi:10.1176/appi.ps.51.2.169 · Cited by 40
Fluoxetine as a Potential Pharmacotherapy for Methamphetamine Dependence
Takamatsu, Y., Yamamoto, H., Ogai, Y., Hagino, Y., Markou, A., & Ikeda, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.026 · Cited by 39
Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals
Johnson, B. A., Roache, J. D., Ait‐Daoud, N., Wells, L. T., Wallace, C. L., Dawes, M. A., Liu, L., & Wang, X. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.002 · Cited by 38
Aripiprazole as a potential pharmacotherapy for stimulant dependence: Human laboratory studies with d-amphetamine.
Stoops, W. W. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.4.413 · Cited by 38
Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers
Garza, R. D. L., SHOPTAW, S. J., & Newton, T. F. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008456 · Cited by 38
Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d -methamphetamine's positive subjective effects: a preliminary study
Johnson, B. A., Roache, J. D., Bordnick, P. S., & Ait‐Daoud, N. (1999) · Psychopharmacology · doi:10.1007/s002130051007 · Cited by 37
Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase‐3 in caudate‐putamen
Pereira, F. C., Lourenço, E. S., Borges, F., Morgadinho, T., Ribeiro, C., Macedo, T. R. A., & Ali, S. F. (2006) · Synapse · doi:10.1002/syn.20285 · Cited by 37
An Open-Label Pilot Study of Risperidone in the Treatment of Methamphetamine Dependence
Meredith, C. W., Jaffe, C., Yanasak, E., Cherrier, M., & Saxon, A. J. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10399875 · Cited by 37
An Exploratory Study: The Use of Paroxetine for Methamphetamine Craving
Piasecki, M. P., Steinagel, G. M., Thienhaus, O. J., & Kohlenberg, B. S. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399967 · Cited by 35
Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice.
Landa, L., Šulcová, A., & Šlais, K. (2007) · PubMed · Cited by 35
Lobeline effects on tonic and methamphetamine-induced dopamine release
Wilhelm, C., Johnson, R. A., Eshleman, A. J., & Janowsky, A. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.019 · Cited by 34
An open clinical trial of naltrexone for amphetamine dependence: Compliance and tolerability
Jayaram‐Lindström, N., Wennberg, P., Beck, O., & Franck, J. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480510023052 · Cited by 33
Modafinil in Diurnal Sleepiness. A Study of 123 Patients
Laffont, F., Mayer, G. J., & Minz, M. (1994) · SLEEP · doi:10.1093/sleep/17.suppl_8.s113 · Cited by 33
Tobacco addiction and pharmacological interventions
Garrett, B. E., Rose, C. A., & Henningfield, J. E. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.10.1545 · Cited by 32
Treatment for amphetamine withdrawal
Srisurapanont, M., Jarusuraisin, N., & Kittirattanapaiboon, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003021 · Cited by 27
Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
Wilhelm, C., Johnson, R. A., Lysko, P. G., Eshleman, A. J., & Janowsky, A. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067314 · Cited by 27
The future of vaccines in the management of addictive disorders
Orson, F. M., Kinsey, B. M., Singh, R. A. K., Wu, Y. L., Gardner, T. J., & Kosten, T. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0049-z · Cited by 24
Methamphetamine Quantitative Urine Concentrations during a Controlled Trial of Fluoxetine Treatment: Preliminary Analysis
Batki, S. L., MOON, J., Delucchi, K., Bradley, M. S., HERSH, D., Smolar, S., Mengis, M. M., LEFKOWITZ, E., SEXE, D., MORELLO, L., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06688.x · Cited by 21
Self-citation
The role of substitute therapy in the treatment of problem amphetamine use
Klee, H., Wright, S., Carnwath, T., & MERRILL, J. (2001) · Drug and Alcohol Review · doi:10.1080/09595230120092715 · Cited by 21
Open-Label Study of a Proprietary Treatment Program Targeting Type A γ-Aminobutyric Acid Receptor Dysregulation in Methamphetamine Dependence
Urschel, H. C., Hanselka, L. L., Gromov, I., White, L., & Baron, M. I. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.10.1170 · Cited by 20
The cardiovascular and subjective effects of methamphetamine combined with γ-vinyl-γ-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers
Garza, R. D. L., Zorick, T. S., Heinzerling, K. G., Nusinowitz, S., London, E. D., SHOPTAW, S. J., Moody, D. E., & Newton, T. F. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.08.007 · Cited by 20
Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons
Daniels, J., Wessinger, W. D., Hardwick, W. C., Li, M., Gunnell, M. G., Hall, C., Owens, S. M., & McMillan, D. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0299-6 · Cited by 18
Involvement of 5‐HT3receptors in the development and expression of methamphetamine‐induced behavioral sensitization: 5‐HT3Areceptor channel and binding study
Yoo, J., Cho, J.-H., Yu, H., Lee, K., Lee, B., Jeong, S. M., Nah, S.-Y., Kim, H., Lee, S., & Jang, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04137.x · Cited by 17
Biotechnology and the Treatment of Addictive Disorders
Elkashef, A. M., Biswas, J., Acri, J. B., & Vocci, F. J. (2007) · BioDrugs · doi:10.2165/00063030-200721040-00006 · Cited by 16
The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
Gibb, J. W., Dm, S., Dc, S., & Gr, H. (1987) · PubMed · Cited by 13
Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues
Danger, Y., Gadjou, C., Devys, A., Galons, H., Blanchard, D., & Folléa, G. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.10.017 · Cited by 11
Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals
Johnson, B. A., Wells, L. T., Roache, J. D., Wallace, C. L., Ait‐Daoud, N., Dawes, M. A., Liu, L., Wang, X., & Javors, M. A. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.011 · Cited by 9
Effects of Tetrabenazine on Methamphetamine-Induced Hyperactivity in Mice are Dependent on Order and Time-Course of Administration
Kuribara, H. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00123-2 · Cited by 7
Drug-induced psychosis associated with crystalline methamphetamine
Dore, G., & Sweeting, M. (2006) · Australasian Psychiatry · doi:10.1111/j.1440-1665.2006.02252.x · Cited by 7
Is Hepatitis C Infection Associated with Increased Risk of Depression in Persons with Methamphetamine Dependence?
Vigil, O., Woods, S. P., Moran, L. M., Letendre, S. L., Casey, C. Y., Grant, I., & Atkinson, J. H. (2007) · American Journal on Addictions · doi:10.1080/10550490701525731 · Cited by 3
[Modafinil (Midiodal): wakefulness stimulant in narcoleptic patients].
Arnulf, I., & Derenne, J. (2000) · PubMed · Cited by 2

Research works printed but not linked: 4

Urschel HC, 2008, A controlled trial of flumazenil, gabapentin and hydroxyzine in treatment of methamphetamine dependence, Puerto Rico, 56
Batki SL, 1999, Fluoxetine in methamphetamine dependence. A controlled trial: a preliminary analysis, Acapulco, 235
Batki SL, 2002, Methamphetamine‐amlodipine interactions: preliminary analysis, Drug Alcohol Depend, 66, S12
Batki SL, 2001, Amlodipine treatment of methamphetamine dependence, a controlled outpatient trial: preliminary analysis, Drug Alcohol Depend, 63, 12

Sorted by citations

Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Courtney, K. E., & Ray, L. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.003 · Cited by 502
“…dependence identified only three ouble-blind placebo-controlled trials that have shown positive esults for reducing use of the substance (Karila et al., 2010). he first two trials found treatment effects within a specific ubpopulation of users; namely buproprion was associated…”
BackgroundInfluential
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
“first-line treatments for substance-use disorders [177].”
Gamma-aminobutyric acid and probiotics: Multiple health benefits and their future in the global functional food and nutraceuticals market
Diez-Gutiérrez, L., Vicente, L. S., Barrón, L. J. R., Villarán, M. C., & Chávarri, M. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103669 · Cited by 277
Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”
Coppola, M., & Mondola, R. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.009 · Cited by 239
Mirtazapine to Reduce Methamphetamine Use: A Randomized Controlled Trial
Colfax, G. N. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.124 · Cited by 175

See all 243

Authors: Karila, L., Weinstein, A., Aubin, H., Benyamina, A., Reynaud, M., & Batki, S. L.
Affiliations: Inserm (FR)
Hadassah Medical Center (IL)
San Francisco VA Medical Center (US)
Corresponding author: Karila, Laurent
ORCID: Karila, Laurent
Weinstein, Aviv
Aubin, Henri‐Jean
Benyamina, Amine
Reynaud, Michel
Batki, Steven L.
Venue: British Journal of Clinical Pharmacology
Publisher: Wiley
Published: 2010-05-10
Volume: 69
Issue: 6
Pages: 578-592
ISSN: 0306-5251 (ISSN-L)
1365-2125
DOI: 10.1111/j.1365-2125.2010.03639.x
PMC: PMC2883750
OpenAlex: W1747110054
Cited by: 242
References: 135
Citations by year: 2026: 8 · 2025: 11 · 2024: 9 · 2023: 12 · 2022: 16 · 2021: 15 · 2020: 8 · 2019: 13 · 2018: 20 · 2017: 15 · 2016: 18 · 2015: 12 · 2014: 16 · 2013: 18 · 2012: 29
FWCI: 2.46
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Clinical Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (U10DA015815, R01DA016764, UG1DA015815)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords: methamphetamine dependence, pharmacotherapy, partial dopamine agonist, aripiprazole, GABAergic agents, gabapentin, serotonergic agents, modafinil, bupropion, naltrexone, d-amphetamine, methylphenidate, drug addiction
MeSH terms: Animals, Calcium Channel Blockers, Humans, Immunotherapy, Methamphetamine, Narcotic Antagonists, Antipsychotic Agents, Neurotransmitter Agents, Amphetamine-Related Disorders, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacological approaches to methamphetamine dependence: a focused review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks